Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Shares Outstanding (Diluted Average) (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Shares Outstanding (Diluted Average) data on record, last reported at $3.8 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) fell 90.33% year-over-year to $3.8 million; the TTM value through Sep 2025 reached $3.8 million, down 90.33%, while the annual FY2024 figure was $1.9 million, 49.84% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $3.8 million in Q3 2025 per COEP's latest filing, up from $3.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $39.8 million in Q3 2024 and bottomed at $1.3 million in Q4 2023.
  • Average Shares Outstanding (Diluted Average) over 5 years is $15.0 million, with a median of $12.7 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Diluted Average): soared 76.98% in 2024, then plummeted 91.35% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $10.9 million in 2021, then soared by 30.98% to $14.3 million in 2022, then crashed by 91.01% to $1.3 million in 2023, then soared by 49.84% to $1.9 million in 2024, then soared by 99.92% to $3.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $3.8 million in Q3 2025, $3.4 million in Q2 2025, and $3.1 million in Q1 2025.